-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: June 2011
Approps Amendment Sets a Dangerous Precedent
A number of media outlets including the New York Times reported on the June 15 vote on the House floor to deny funding for authorization of the genetically engineered AquAdvantage salmon. In response, BIO President and CEO Jim Greenwood admonished the action for setting a dangerous and inappropriate precedent. “This amendment does a grave disservice to our Government’s science-based regulatory system. President Obama has called for America to lead on new technologies so as to Read More >
2011 BIO International Convention Preview
Andrew Williams, from Patent Docs wrote a nice blog on the upcoming 2011 BIO International Convention. Therefore, over the next week, Patent Docs will be highlighting a few sessions or other opportunities, in thematic fashion, to help you navigate your way through the convention. For example, today we present opportunities for those intested in learning more about how the Supreme Court is impacting the BIO community. Take a look at his entry, and keep an Read More >
Translational Research Forum at BIO International Convention
BIO is hosting a Translation Research Forum at the BIO International Convention. NIH Director Collins keynotes an event that will explore how private, public and academic sectors can leverage meaningful partnerships, highlight emerging best practices, explore risk-sharing at the clinical research stage, and explore ways to bridge the gap in funding and know-how necessary to take university research to the next level. Read the Press Release for more information about panels and speakers. For registration, conference Read More >
University-Industry Partnering at BIO Convention Webinar by AUTM June 16, 3-4PM
Get the inside information on what industry does and does NOT want from their academic counterparts: Join us June 16, 3-4 p.m. EDT for Insider’s Guide to Effective Partnering at BIO 2011, a FREE AUTM webinar to help you prepare for the BIO convention in Washington, DC, June 27-30.
BIO has issued a strong letter of support for the Manager’s Amendment to H.R. 1249, the America Invents Act
by Stephanie D. Fischer BIO has issued a strong letter of support for the Manager’s Amendment to H.R. 1249, the America Invents Act. The letter is posted on our website and the text is below: “On behalf of the Biotechnology Industry Organization (BIO), I am writing to express our strong support for your Manager’s Amendment to H.R. 1249, the America Invents Act. It is our strong desire to see this bill, as amended, passed by Read More >
